Detalhe da pesquisa
1.
SLC25A51 is a mammalian mitochondrial NAD+ transporter.
Nature
; 588(7836): 174-179, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32906142
2.
Oral gepotidacin versus nitrofurantoin in patients with uncomplicated urinary tract infection (EAGLE-2 and EAGLE-3): two randomised, controlled, double-blind, double-dummy, phase 3, non-inferiority trials.
Lancet
; 403(10428): 741-755, 2024 Feb 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38342126
3.
Dose selection for a phase III study evaluating gepotidacin (GSK2140944) in the treatment of uncomplicated urogenital gonorrhoea.
Sex Transm Infect
; 99(1): 64-69, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36411033
4.
Pharmacokinetics of Oral Formulations of Gepotidacin (GSK2140944), a Triazaacenaphthylene Bacterial Type II Topoisomerase Inhibitor, in Healthy Adult and Adolescent Participants.
Antimicrob Agents Chemother
; 66(1): e0126321, 2022 01 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-34633853
5.
Dose Selection for Phase III Clinical Evaluation of Gepotidacin (GSK2140944) in the Treatment of Uncomplicated Urinary Tract Infections.
Antimicrob Agents Chemother
; 66(3): e0149221, 2022 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34978887
6.
Comparison between physiologically based pharmacokinetic and population pharmacokinetic modelling to select paediatric doses of gepotidacin in plague.
Br J Clin Pharmacol
; 88(2): 416-428, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34289143
7.
Cancer aided by greasy traitors.
Nature
; 591(7849): 204-206, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33627861
8.
Regulation of nuclear epigenome by mitochondrial DNA heteroplasmy.
Proc Natl Acad Sci U S A
; 116(32): 16028-16035, 2019 08 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31253706
9.
Microbiome recovery in adult females with uncomplicated urinary tract infections in a randomised phase 2A trial of the novel antibiotic gepotidacin (GSK140944).
BMC Microbiol
; 21(1): 181, 2021 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34130619
10.
MYC regulates fatty acid metabolism through a multigenic program in claudin-low triple negative breast cancer.
Br J Cancer
; 122(6): 868-884, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31942031
11.
Phase 2a Pharmacokinetic, Safety, and Exploratory Efficacy Evaluation of Oral Gepotidacin (GSK2140944) in Female Participants with Uncomplicated Urinary Tract Infection (Acute Uncomplicated Cystitis).
Antimicrob Agents Chemother
; 64(7)2020 06 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-32284384
12.
In Vitro Activity and Microbiological Efficacy of Gepotidacin from a Phase 2, Randomized, Multicenter, Dose-Ranging Study in Patients with Acute Bacterial Skin and Skin Structure Infections.
Antimicrob Agents Chemother
; 64(3)2020 02 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-31818823
13.
Tissue metabolic profiling shows that saccharopine accumulates during renal ischemic-reperfusion injury, while kynurenine and itaconate accumulate in renal allograft rejection.
Metabolomics
; 16(5): 65, 2020 05 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32367163
14.
Using rapid point-of-care tests to inform antibiotic choice to mitigate drug resistance in gonorrhoea.
Euro Surveill
; 25(43)2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33124551
15.
Gepotidacin for the Treatment of Uncomplicated Urogenital Gonorrhea: A Phase 2, Randomized, Dose-Ranging, Single-Oral Dose Evaluation.
Clin Infect Dis
; 67(4): 504-512, 2018 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29617982
16.
Microbiological Analysis from a Phase 2 Randomized Study in Adults Evaluating Single Oral Doses of Gepotidacin in the Treatment of Uncomplicated Urogenital Gonorrhea Caused by Neisseria gonorrhoeae.
Antimicrob Agents Chemother
; 62(12)2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30249694
17.
Efficacy, Safety, and Tolerability of Gepotidacin (GSK2140944) in the Treatment of Patients with Suspected or Confirmed Gram-Positive Acute Bacterial Skin and Skin Structure Infections.
Antimicrob Agents Chemother
; 61(6)2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28373199
18.
Efficacy and safety of once-weekly GLP-1 receptor agonist albiglutide (HARMONY 2): 52 week primary endpoint results from a randomised, placebo-controlled trial in patients with type 2 diabetes mellitus inadequately controlled with diet and exercise.
Diabetologia
; 59(2): 266-74, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26577795
19.
Correction to: Microbiome recovery in adult females with uncomplicated urinary tract infections in a randomised phase 2A trial of the novel antibiotic gepotidacin (GSK2140944).
BMC Microbiol
; 21(1): 293, 2021 Oct 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-34702186
20.
HARMONY 4: randomised clinical trial comparing once-weekly albiglutide and insulin glargine in patients with type 2 diabetes inadequately controlled with metformin with or without sulfonylurea.
Diabetologia
; 57(12): 2475-84, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25208756